Vital Farms price target lowered to $45 from $48 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Vital Farms (VITL) to $45 from $48 and keeps an Overweight rating on the shares. At its investor day, Vital updated its long-term algorithm with above-consensus targets, though this was overshadowed and yesterday’s stock reaction was driven by an “unexpected” FY25 revenue guidance cut, the analyst tells investors. However, the firm sees the event providing greater visibility into “a long, underappreciated growth runway,” the analyst added.